CN116884566A - Medication risk monitoring and evaluating method and system - Google Patents
Medication risk monitoring and evaluating method and system Download PDFInfo
- Publication number
- CN116884566A CN116884566A CN202310863813.2A CN202310863813A CN116884566A CN 116884566 A CN116884566 A CN 116884566A CN 202310863813 A CN202310863813 A CN 202310863813A CN 116884566 A CN116884566 A CN 116884566A
- Authority
- CN
- China
- Prior art keywords
- information
- monitoring
- medication
- risk
- mobile terminal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 274
- 229940079593 drug Drugs 0.000 title claims abstract description 214
- 238000012544 monitoring process Methods 0.000 title claims abstract description 194
- 238000000034 method Methods 0.000 title claims abstract description 36
- 238000012502 risk assessment Methods 0.000 claims abstract description 65
- 238000013475 authorization Methods 0.000 claims description 25
- 238000004458 analytical method Methods 0.000 claims description 15
- 238000010276 construction Methods 0.000 claims description 11
- 230000005856 abnormality Effects 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 6
- 238000011269 treatment regimen Methods 0.000 claims description 4
- 206010067484 Adverse reaction Diseases 0.000 description 7
- 230000006838 adverse reaction Effects 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 230000036760 body temperature Effects 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 238000007726 management method Methods 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 238000011161 development Methods 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013523 data management Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention provides a medication risk monitoring and evaluating method and a system, wherein the method comprises the following steps: when receiving a medication risk monitoring application sent by a user through a mobile terminal, outputting a preset acquisition flow of first information of medication risk monitoring to the mobile terminal; constructing a monitoring task based on first information acquired through the mobile terminal; acquiring second information of the current medication sent by the mobile terminal when the monitoring task is executed; and generating risk assessment information based on the second information and sending the risk assessment information to the mobile terminal. According to the medication risk monitoring and evaluating method, risk monitoring and evaluating are carried out on each medication of the medication object, so that medication safety of the medication object is ensured.
Description
Technical Field
The invention relates to the technical field of risk monitoring and evaluation, in particular to a medication risk monitoring and evaluation method and system.
Background
The medical industry is one of the emerging industries which are most innovative and rapid in development in a new technological revolution and industrial transformation, is also an important component part of life health industry, and relates people's life health and folk welfare.
Drug alerts are activities that monitor, identify, evaluate and control adverse drug reactions and other adverse drug-related reactions. The medical warning system is formally implemented in the drug warning quality management standard issued by the national drug administration in the year 2021 12 and 1, is an important measure for implementing the drug warning system in the drug administration of the people's republic of China, is a key factor for gradually integrating the global drug warning development pattern in the medical industry, and is a technical guarantee for guaranteeing the public drug safety and comprehensively promoting the construction of healthy salt cities.
The drug alert quality management standard requires two main lines of drug alert activities to be built around a drug alert system and drug risk management, embody the management concept of the whole life cycle of drugs, adhere to the principle of drug risk management, define the responsible undertakers of the drug alert subject, and plan the international development blueprint of enterprises.
In China, drug alert originates from drug adverse reaction monitoring work. In fact, since the implementation of the first part of China, namely the drug administration method, in 1985, the adverse reaction monitoring work has been carried out for over 30 years, and the identification, evaluation and control aspects of drug marketing licensees and drug users on risks are weak; especially, when people use medicines in daily life, doctors conduct medicine dosage guidance according to inquiry conditions, but the illness state is dynamic, the whole medicine dosage guidance cannot be realized, and the medicine risk monitoring and evaluation before each medicine taking in the medicine taking process can be realized, so that the medicine taking safety and the physical health of patients are directly related.
Disclosure of Invention
The invention aims to provide a medication risk monitoring and evaluating method, which is used for carrying out risk monitoring and evaluating on each medication of a medication object and ensuring medication safety of the medication object.
The medication risk monitoring and evaluating method provided by the embodiment of the invention comprises the following steps:
when receiving a medication risk monitoring application sent by a user through a mobile terminal, outputting a preset acquisition flow of first information of medication risk monitoring to the mobile terminal;
constructing a monitoring task based on first information acquired through the mobile terminal;
acquiring second information of the current medication sent by the mobile terminal when the monitoring task is executed;
and generating risk assessment information based on the second information and sending the risk assessment information to the mobile terminal.
Preferably, the mobile terminal executes a first information acquisition procedure, including:
outputting an information acquisition interface of a preset medication object;
acquiring identity information of a medicine object through an information acquisition interface;
and/or the number of the groups of groups,
outputting an image acquisition interface of a preset medicine object;
image information of a medicine object is adopted through an image acquisition interface;
and/or the number of the groups of groups,
outputting a license authorization interface of information query of a preset third party platform;
obtaining license authorization information through a license authorization interface;
acquiring related information of a medication object from a third party platform based on the permission authorization information;
and/or;
outputting a monitoring demand acquisition interface of preset medication monitoring;
and acquiring medication monitoring demand information of the medication object through a monitoring demand acquisition interface.
Preferably, the construction of the monitoring task based on the first information acquired by the mobile terminal includes:
analyzing the first information, and determining identity information, image information, related information and medication monitoring requirement information;
constructing a monitoring drug list based on the drug monitoring requirement information;
based on each drug to be monitored on the monitored drug list, extracting information related to the monitored drug from identity information, image information and related information as information to be analyzed;
determining the monitoring dosage of each drug to be monitored and the triggering condition of re-taking based on the information to be analyzed;
based on the monitored dosage and the triggering condition of taking again, constructing the corresponding monitoring task of each drug to be monitored.
Preferably, the mobile terminal obtains second information of the current medication, including:
acquiring vital sign information of a medication object through a vital sign monitoring terminal worn by the medication object;
and/or the number of the groups of groups,
and acquiring a medicine image of the current medicine.
Preferably, based on the second information, risk assessment information is generated and sent to the mobile terminal, including:
based on the monitored drug list, invoking a risk assessment library;
extracting features of the identity information, the image information and the related information to obtain a plurality of first feature values;
extracting vital sign information in a period from last medication to current medication;
extracting features of the extracted vital sign information to obtain a plurality of second feature values;
drug identification is carried out on the drug image, and identification information is obtained;
extracting features of the identification information to obtain a plurality of third feature values;
constructing a risk analysis parameter set based on the plurality of first feature values, the plurality of second feature values, and the plurality of third feature values;
and determining risk assessment information based on the risk analysis parameter set and the risk assessment library.
Preferably, the medication risk monitoring and evaluating method further comprises:
analyzing risk assessment information and determining a risk monitoring time threshold;
acquiring vital sign information once every other preset time interval in the monitoring time corresponding to the risk monitoring time threshold, and monitoring and analyzing the acquired vital sign information;
when an abnormality occurs, outputting emergency treatment strategy information to the mobile terminal;
the method for monitoring and analyzing the acquired vital sign information comprises the following steps:
extracting features of the vital sign information to obtain a plurality of fourth feature values;
constructing a risk monitoring parameter set based on the first, third and fourth feature values;
acquiring a risk monitoring analysis library associated with a risk assessment library;
determining a risk analysis result based on the risk monitoring analysis library and the risk monitoring parameter set;
analyzing the risk analysis result to determine whether an abnormality occurs.
The invention also provides a medication risk monitoring and evaluating system, which comprises:
the first acquisition module is used for outputting the acquisition flow of the first information of the preset medication risk monitoring to the mobile terminal when receiving the medication risk monitoring application sent by the user through the mobile terminal;
the construction module is used for constructing a monitoring task based on the first information acquired by the mobile terminal;
the second acquisition module is used for acquiring second information of the current medication sent by the mobile terminal when the monitoring task is executed;
and the risk monitoring analysis module is used for generating risk assessment information based on the second information and sending the risk assessment information to the mobile terminal.
Preferably, the mobile terminal executes a first information acquisition procedure, including:
outputting an information acquisition interface of a preset medication object;
acquiring identity information of a medicine object through an information acquisition interface;
and/or the number of the groups of groups,
outputting an image acquisition interface of a preset medicine object;
image information of a medicine object is adopted through an image acquisition interface;
and/or the number of the groups of groups,
outputting a license authorization interface of information query of a preset third party platform;
obtaining license authorization information through a license authorization interface;
acquiring related information of a medication object from a third party platform based on the permission authorization information;
and/or;
outputting a monitoring demand acquisition interface of preset medication monitoring;
and acquiring medication monitoring demand information of the medication object through a monitoring demand acquisition interface.
Preferably, the construction module constructs the monitoring task based on the first information acquired by the mobile terminal, and performs the following operations:
analyzing the first information, and determining identity information, image information, related information and medication monitoring requirement information;
constructing a monitoring drug list based on the drug monitoring requirement information;
based on each drug to be monitored on the monitored drug list, extracting information related to the monitored drug from identity information, image information and related information as information to be analyzed;
determining the monitoring dosage of each drug to be monitored and the triggering condition of re-taking based on the information to be analyzed;
based on the monitored dosage and the triggering condition of taking again, constructing the corresponding monitoring task of each drug to be monitored.
Preferably, the mobile terminal obtains second information of the current medication, including:
acquiring vital sign information of a medication object through a vital sign monitoring terminal worn by the medication object;
and/or the number of the groups of groups,
and acquiring a medicine image of the current medicine.
Additional features and advantages of the invention will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The objectives and other advantages of the invention will be realized and attained by the structure particularly pointed out in the written description and claims thereof as well as the appended drawings.
The technical scheme of the invention is further described in detail through the drawings and the embodiments.
Drawings
The accompanying drawings are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate the invention and together with the embodiments of the invention, serve to explain the invention. In the drawings:
FIG. 1 is a schematic diagram of a medication risk monitoring and evaluating method according to an embodiment of the present invention;
fig. 2 is a schematic diagram of a medication risk monitoring and evaluating system according to an embodiment of the present invention.
The preferred embodiments of the present invention will be described below with reference to the accompanying drawings, it being understood that the preferred embodiments described herein are for illustration and explanation of the present invention only, and are not intended to limit the present invention.
The embodiment of the invention provides a medication risk monitoring and evaluating method, which is shown in fig. 1 and comprises the following steps:
step S1: when receiving a medication risk monitoring application sent by a user through a mobile terminal, outputting a preset acquisition flow of first information of medication risk monitoring to the mobile terminal;
step S2: constructing a monitoring task based on first information acquired through the mobile terminal;
step S3: acquiring second information of the current medication sent by the mobile terminal when the monitoring task is executed;
step S4: and generating risk assessment information based on the second information and sending the risk assessment information to the mobile terminal.
According to the medication risk monitoring and evaluating method, a user is first required to operate through a mobile terminal to realize the construction of a monitoring task, then the monitoring task is executed, medication condition information (namely second information) in the execution process of the monitoring task is obtained, then risk evaluation is carried out on the condition information, and risk evaluation information is generated; according to the medication risk monitoring and evaluating method, the mode of a monitoring task is established through information input by a user, and risk evaluation is carried out on the current medication every time the monitoring task is executed, so that the whole-flow monitoring of the medication process is realized, and the medication safety of a medication object is ensured.
In one embodiment, the mobile terminal executes a first information acquisition procedure, including:
outputting an information acquisition interface of a preset medication object;
acquiring identity information of a medicine object through an information acquisition interface;
and/or the number of the groups of groups,
outputting an image acquisition interface of a preset medicine object;
image information of a medicine object is adopted through an image acquisition interface;
and/or the number of the groups of groups,
outputting a license authorization interface of information query of a preset third party platform;
obtaining license authorization information through a license authorization interface;
acquiring related information of a medication object from a third party platform based on the permission authorization information;
and/or;
outputting a monitoring demand acquisition interface of preset medication monitoring;
and acquiring medication monitoring demand information of the medication object through a monitoring demand acquisition interface.
Collecting identity information of a medication object through an information collection interface of the medication object; the identity information includes: age, height, weight, name, etc.; the image information of the medicine object is acquired through the image acquisition interface, and the information such as age, height, weight and the like can be identified through the image information; acquiring related information of a medicine object from a third party platform through acquiring permission authorization of a user; the third party platform comprises a data management platform of a hospital, and the acquired related information comprises a diagnosis record, allergen data and the like; in addition, the medication monitoring requirement information of the medication object is collected through the monitoring requirement collection interface, and the medication monitoring requirement information comprises: information of the medicine to be monitored, the dosage of the medicine, etc.; before the mobile terminal sends the data to the system, integrating the identity information of the medicine object, the image information of the medicine object, the related information of the medicine object on the third party platform and the medicine monitoring requirement information of the medicine object into first information for sending.
To implement the construction of the monitoring task, in one embodiment, the construction of the monitoring task based on the first information acquired through the mobile terminal includes:
analyzing the first information, and determining identity information, image information, related information and medication monitoring requirement information; the analysis process is the reverse process of data integration of the mobile terminal for data transmission; the data integration comprises ordering and compiling of the data;
constructing a monitoring drug list based on the drug monitoring requirement information; monitoring each drug on the drug list to correspond to each monitoring requirement in the drug monitoring requirement information;
based on each drug to be monitored on the monitored drug list, extracting information related to the monitored drug from identity information, image information and related information as information to be analyzed; the dosage of the medicine is determined according to the weight of the human body, and the dosage of the medicine is determined according to the age of the human body;
determining the monitoring dosage of each drug to be monitored and the triggering condition of re-taking based on the information to be analyzed; triggering conditions for re-administration include: time, body temperature, etc.;
based on the monitored dosage and the triggering condition of taking again, constructing the corresponding monitoring task of each drug to be monitored.
In order to achieve the second information acquisition, in one embodiment, the mobile terminal acquires second information of the current medication, including:
acquiring vital sign information of a medication object through a vital sign monitoring terminal worn by the medication object; such as smart wristbands, etc.; the vital sign information includes: body temperature, pulse, heart rate, blood oxygen concentration, etc.;
and/or the number of the groups of groups,
and acquiring a medicine image of the current medicine. Shooting a medicine image through a camera of the mobile terminal or a shooting device in communication connection with the mobile terminal; when the method is applied specifically, a user shoots medicines currently taken by a medicine taking object together to form a medicine image;
according to the embodiment, the vital sign information of the medicine taking object and the medicine image of the medicine are obtained, so that the vital signs of the medicine taking object before, during and after the medicine taking object is monitored, the physical state of the medicine taking object is determined, the current medicine image is shot, and the current medicine dosage and whether the medicine taking is wrong or not can be determined.
In one embodiment, based on the second information, risk assessment information is generated and sent to the mobile terminal, including:
based on the monitored drug list, invoking a risk assessment library; the corresponding risk assessment library is called through monitoring the drug types and names of the drug lists; the risk assessment library is constructed by professional analysis based on poor drug data in advance; different drug types used for treating different symptoms are combined to be used as corresponding references;
extracting features of the identity information, the image information and the related information to obtain a plurality of first feature values; the first characteristic value includes: a characteristic value indicating height, a characteristic value indicating weight, a characteristic value indicating age, and the like;
extracting vital sign information in a period from last medication to current medication;
extracting features of the extracted vital sign information to obtain a plurality of second feature values; the second characteristic value comprises a body temperature average value, a body temperature maximum value, a heart rate average value, an oxygen concentration maximum value, an oxygen concentration average value, a pulse maximum value, a pulse average value and the like;
drug identification is carried out on the drug image, and identification information is obtained; the identification information includes the kind and the number of the medicines;
extracting features of the identification information to obtain a plurality of third feature values; the third characteristic value includes: a category code representing a category of the drug and a characteristic value representing a corresponding number;
constructing a risk analysis parameter set based on the plurality of first feature values, the plurality of second feature values, and the plurality of third feature values; sequentially arranging the first characteristic value, the second characteristic value and the third characteristic value to form a risk analysis parameter set;
and determining risk assessment information based on the risk analysis parameter set and the risk assessment library. Risk analysis parameter sets and risk assessment information are in one-to-one correspondence in a risk assessment library. The risk assessment information includes: a risk monitoring time threshold (the length of time required to monitor vital signs after administration), the probability of no adverse events, adverse reactions, etc.; the determination of the probability of adverse reaction is mainly based on data analysis after taking corresponding medicines obtained by investigation when a risk assessment library is constructed; for example: the effect tracking is carried out on 1000 persons taking medicines during investigation, and when 2 persons taking medicines have adverse reactions, the corresponding probability is two thousandths;
for risk monitoring after a prior administration, in one embodiment, the medication risk monitoring and evaluating method further comprises:
analyzing risk assessment information and determining a risk monitoring time threshold; different risk monitoring time thresholds for different drugs to be taken, for example, the higher the reject ratio is, the longer the corresponding risk monitoring time threshold is; the greater the harm of the adverse reaction to the human body, the longer the corresponding risk monitoring time threshold;
acquiring vital sign information once every other preset time interval (30 seconds) in the monitoring time corresponding to the risk monitoring time threshold, and monitoring and analyzing the acquired vital sign information;
when an abnormality occurs, outputting emergency treatment strategy information to the mobile terminal;
the method for monitoring and analyzing the acquired vital sign information comprises the following steps:
extracting features of the vital sign information to obtain a plurality of fourth feature values; the fourth characteristic value comprises a body temperature average value, a body temperature maximum value, a heart rate average value, an oxygen concentration maximum value, an oxygen concentration average value, a pulse maximum value, a pulse average value and the like;
constructing a risk monitoring parameter set based on the first, third and fourth feature values;
acquiring a risk monitoring analysis library associated with a risk assessment library;
determining a risk analysis result based on the risk monitoring analysis library and the risk monitoring parameter set; the risk monitoring parameter sets are associated with risk analysis results in a risk monitoring analysis library in a one-to-one correspondence manner;
analyzing the risk analysis result to determine whether an abnormality occurs.
In addition, adverse reaction records can be obtained through risk monitoring after taking the medicine, and a data basis is provided for updating a risk assessment library.
The invention also provides a medication risk monitoring and evaluating system, as shown in fig. 2, comprising:
the first acquisition module 1 is used for outputting an acquisition flow of first information of preset medication risk monitoring to the mobile terminal when receiving a medication risk monitoring application sent by a user through the mobile terminal;
the construction module 2 is used for constructing a monitoring task based on the first information acquired by the mobile terminal;
the second acquisition module 3 is used for acquiring second information of the current medication sent by the mobile terminal when the monitoring task is executed;
and the risk monitoring analysis module 4 is used for generating risk assessment information based on the second information and sending the risk assessment information to the mobile terminal.
Preferably, the mobile terminal executes a first information acquisition procedure, including:
outputting an information acquisition interface of a preset medication object;
acquiring identity information of a medicine object through an information acquisition interface;
and/or the number of the groups of groups,
outputting an image acquisition interface of a preset medicine object;
image information of a medicine object is adopted through an image acquisition interface;
and/or the number of the groups of groups,
outputting a license authorization interface of information query of a preset third party platform;
obtaining license authorization information through a license authorization interface;
acquiring related information of a medication object from a third party platform based on the permission authorization information;
and/or;
outputting a monitoring demand acquisition interface of preset medication monitoring;
and acquiring medication monitoring demand information of the medication object through a monitoring demand acquisition interface.
Preferably, the construction module constructs the monitoring task based on the first information acquired by the mobile terminal, and performs the following operations:
analyzing the first information, and determining identity information, image information, related information and medication monitoring requirement information;
constructing a monitoring drug list based on the drug monitoring requirement information;
based on each drug to be monitored on the monitored drug list, extracting information related to the monitored drug from identity information, image information and related information as information to be analyzed;
determining the monitoring dosage of each drug to be monitored and the triggering condition of re-taking based on the information to be analyzed;
based on the monitored dosage and the triggering condition of taking again, constructing the corresponding monitoring task of each drug to be monitored.
Preferably, the mobile terminal obtains second information of the current medication, including:
acquiring vital sign information of a medication object through a vital sign monitoring terminal worn by the medication object;
and/or the number of the groups of groups,
and acquiring a medicine image of the current medicine.
Preferably, the risk monitoring analysis module generates risk assessment information based on the second information and sends the risk assessment information to the mobile terminal, and performs the following operations:
based on the monitored drug list, invoking a risk assessment library;
extracting features of the identity information, the image information and the related information to obtain a plurality of first feature values;
extracting vital sign information in a period from last medication to current medication;
extracting features of the extracted vital sign information to obtain a plurality of second feature values;
drug identification is carried out on the drug image, and identification information is obtained;
extracting features of the identification information to obtain a plurality of third feature values;
constructing a risk analysis parameter set based on the plurality of first feature values, the plurality of second feature values, and the plurality of third feature values;
and determining risk assessment information based on the risk analysis parameter set and the risk assessment library.
Preferably, the medication risk monitoring and evaluating system further comprises: an anomaly monitoring module;
the anomaly monitoring module performs the following operations:
analyzing risk assessment information and determining a risk monitoring time threshold;
acquiring vital sign information once every other preset time interval in the monitoring time corresponding to the risk monitoring time threshold, and monitoring and analyzing the acquired vital sign information;
when an abnormality occurs, outputting emergency treatment strategy information to the mobile terminal;
the method for monitoring and analyzing the acquired vital sign information comprises the following steps:
extracting features of the vital sign information to obtain a plurality of fourth feature values;
constructing a risk monitoring parameter set based on the first, third and fourth feature values;
acquiring a risk monitoring analysis library associated with a risk assessment library;
determining a risk analysis result based on the risk monitoring analysis library and the risk monitoring parameter set;
analyzing the risk analysis result to determine whether an abnormality occurs.
It will be apparent to those skilled in the art that various modifications and variations can be made to the present invention without departing from the spirit or scope of the invention. Thus, it is intended that the present invention also include such modifications and alterations insofar as they come within the scope of the appended claims or the equivalents thereof.
Claims (10)
1. A medication risk monitoring and assessment method, comprising:
when receiving a medication risk monitoring application sent by a user through a mobile terminal, outputting a preset acquisition flow of first information of medication risk monitoring to the mobile terminal;
constructing a monitoring task based on first information acquired by the mobile terminal;
acquiring second information of the current medication sent by the mobile terminal when the monitoring task is executed;
and generating risk assessment information based on the second information and sending the risk assessment information to the mobile terminal.
2. The medication risk monitoring and assessment method according to claim 1, wherein the mobile terminal performs a first information acquisition procedure comprising:
outputting an information acquisition interface of a preset medication object;
acquiring identity information of a medication object through the information acquisition interface;
and/or the number of the groups of groups,
outputting an image acquisition interface of a preset medicine object;
image information of a medicine object is adopted through the image acquisition interface;
and/or the number of the groups of groups,
outputting a license authorization interface of information query of a preset third party platform;
obtaining license authorization information through the license authorization interface;
acquiring related information of a medication object from a third party platform based on the license authorization information;
and/or;
outputting a monitoring demand acquisition interface of preset medication monitoring;
and acquiring medication monitoring demand information of the medication object through the monitoring demand acquisition interface.
3. The medication risk monitoring and assessment method according to claim 2, wherein said constructing a monitoring task based on the first information obtained by the mobile terminal comprises:
analyzing the first information, and determining identity information, image information, related information and medication monitoring requirement information;
constructing a monitoring drug list based on the drug monitoring requirement information;
based on each drug to be monitored on the monitored drug list, extracting information related to the monitored drug from identity information, image information and related information as information to be analyzed;
determining the monitoring dosage of each drug to be monitored and the triggering condition of taking again based on the information to be analyzed;
and constructing a monitoring task corresponding to each drug to be monitored based on the monitoring dose and the triggering condition of re-taking.
4. The medication risk monitoring and assessment method according to claim 1, wherein the mobile terminal obtaining second information of the current medication comprises:
acquiring vital sign information of a medication object through a vital sign monitoring terminal worn by the medication object;
and/or the number of the groups of groups,
and acquiring a medicine image of the current medicine.
5. The medication risk monitoring and assessment method according to claim 4, wherein said generating and transmitting risk assessment information to said mobile terminal based on said second information comprises:
based on the monitored drug list, invoking a risk assessment library;
extracting features of the identity information, the image information and the related information to obtain a plurality of first feature values;
extracting the vital sign information in the period from the last medication to the current medication;
extracting features of the extracted vital sign information to obtain a plurality of second feature values;
carrying out medicine identification on the medicine image to obtain identification information;
extracting features of the identification information to obtain a plurality of third feature values;
constructing a risk analysis parameter set based on the plurality of first feature values, the plurality of second feature values, and the plurality of third feature values;
the risk assessment information is determined based on the risk analysis parameter set and the risk assessment library.
6. The medication risk monitoring and assessment method of claim 5, further comprising:
analyzing the risk assessment information to determine a risk monitoring time threshold;
acquiring vital sign information once every other preset time interval in the monitoring time corresponding to the risk monitoring time threshold, and monitoring and analyzing the acquired vital sign information;
when an abnormality occurs, outputting emergency treatment strategy information to the mobile terminal;
the method for monitoring and analyzing the acquired vital sign information comprises the following steps:
extracting features of the vital sign information to obtain a plurality of fourth feature values;
constructing a risk monitoring parameter set based on the first, third and fourth feature values;
acquiring a risk monitoring analysis library associated with the risk assessment library;
determining a risk analysis result based on the risk monitoring analysis library and the risk monitoring parameter set;
analyzing the risk analysis result to determine whether an abnormality occurs.
7. A medication risk monitoring and assessment system, comprising:
the mobile terminal comprises a first acquisition module, a second acquisition module and a third acquisition module, wherein the first acquisition module is used for outputting the acquisition flow of first information of preset medication risk monitoring to the mobile terminal when receiving a medication risk monitoring application sent by a user through the mobile terminal;
the construction module is used for constructing a monitoring task based on the first information acquired by the mobile terminal;
the second acquisition module is used for acquiring second information of the current medication sent by the mobile terminal when the monitoring task is executed;
and the risk monitoring analysis module is used for generating risk assessment information based on the second information and sending the risk assessment information to the mobile terminal.
8. The medication risk monitoring and assessment system of claim 7, wherein the mobile terminal performs a first information acquisition process comprising:
outputting an information acquisition interface of a preset medication object;
acquiring identity information of a medication object through the information acquisition interface;
and/or the number of the groups of groups,
outputting an image acquisition interface of a preset medicine object;
image information of a medicine object is adopted through the image acquisition interface;
and/or the number of the groups of groups,
outputting a license authorization interface of information query of a preset third party platform;
obtaining license authorization information through the license authorization interface;
acquiring related information of a medication object from a third party platform based on the license authorization information;
and/or;
outputting a monitoring demand acquisition interface of preset medication monitoring;
and acquiring medication monitoring demand information of the medication object through the monitoring demand acquisition interface.
9. The medication risk monitoring and assessment system according to claim 8, wherein said construction module constructs a monitoring task based on the first information obtained by said mobile terminal, performing the following operations:
analyzing the first information, and determining identity information, image information, related information and medication monitoring requirement information;
constructing a monitoring drug list based on the drug monitoring requirement information;
based on each drug to be monitored on the monitored drug list, extracting information related to the monitored drug from identity information, image information and related information as information to be analyzed;
determining the monitoring dosage of each drug to be monitored and the triggering condition of taking again based on the information to be analyzed;
and constructing a monitoring task corresponding to each drug to be monitored based on the monitoring dose and the triggering condition of re-taking.
10. The medication risk monitoring and assessment system of claim 7, wherein the mobile terminal obtaining second information of the current medication comprises:
acquiring vital sign information of a medication object through a vital sign monitoring terminal worn by the medication object;
and/or the number of the groups of groups,
and acquiring a medicine image of the current medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310863813.2A CN116884566A (en) | 2023-07-14 | 2023-07-14 | Medication risk monitoring and evaluating method and system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310863813.2A CN116884566A (en) | 2023-07-14 | 2023-07-14 | Medication risk monitoring and evaluating method and system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116884566A true CN116884566A (en) | 2023-10-13 |
Family
ID=88263953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310863813.2A Pending CN116884566A (en) | 2023-07-14 | 2023-07-14 | Medication risk monitoring and evaluating method and system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116884566A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105139083A (en) * | 2015-08-10 | 2015-12-09 | 石庆平 | Method and system for reevaluating safety of drug after appearance on market |
| CN106108846A (en) * | 2016-06-20 | 2016-11-16 | 中山大学 | A kind of intelligent drug risk monitoring method and system |
| CN109543863A (en) * | 2018-10-27 | 2019-03-29 | 平安医疗健康管理股份有限公司 | A kind of medical treatment task management method, server and storage medium |
| CN111564195A (en) * | 2020-04-30 | 2020-08-21 | 安徽省立医院(中国科学技术大学附属第一医院) | System and method for evaluating risk of multiple medication of old patients |
-
2023
- 2023-07-14 CN CN202310863813.2A patent/CN116884566A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105139083A (en) * | 2015-08-10 | 2015-12-09 | 石庆平 | Method and system for reevaluating safety of drug after appearance on market |
| CN106108846A (en) * | 2016-06-20 | 2016-11-16 | 中山大学 | A kind of intelligent drug risk monitoring method and system |
| CN109543863A (en) * | 2018-10-27 | 2019-03-29 | 平安医疗健康管理股份有限公司 | A kind of medical treatment task management method, server and storage medium |
| CN111564195A (en) * | 2020-04-30 | 2020-08-21 | 安徽省立医院(中国科学技术大学附属第一医院) | System and method for evaluating risk of multiple medication of old patients |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20180137247A1 (en) | Preventive and predictive health platform | |
| CN107851460B (en) | Global unified registration and universal identification method for donors | |
| US20120022886A1 (en) | Medical Data Acquisition, Diagnostic and Communication System | |
| JP2007516024A (en) | Systems and methods for processing and displaying arrhythmia information to facilitate identification and treatment of cardiac arrhythmias | |
| Khan et al. | IoT based on secure personal healthcare using RFID technology and steganography | |
| US10980417B2 (en) | Acute care eco system integrating customized devices of personalized care with networked population based management | |
| CN112309552A (en) | AI-based bracelet-type intelligent whole-course radiotherapy safety management system and method | |
| US20240062856A1 (en) | Medical survey trigger and presentation | |
| Thomas et al. | Home-based assessment of cognition and health measures: The collaborative aging research using technology (CART) initiative and international collaborations | |
| US20240032853A1 (en) | Method and Apparatus for Detecting Conditions from Physiology Data | |
| CN106606348A (en) | System for monitoring life safety, health and living safety of the elderly based on mobile communication | |
| CN113724895A (en) | Day operation postoperative health monitoring system and method and health management platform | |
| CN116705264A (en) | Medical record timing medicine taking reminding system | |
| CN116884566A (en) | Medication risk monitoring and evaluating method and system | |
| CN115831298A (en) | Clinical trial patient recruitment method and device based on hospital management information system | |
| Shin et al. | Ubiquitous healthcare platform for chronic patients | |
| US20160259917A1 (en) | Method for creating and using registry of clinical trial participants | |
| CN110867248A (en) | Postoperative monitoring method and device | |
| Dey et al. | Patient Health Observation and Analysis with Machine Learning and IoT Based in Realtime Environment | |
| CN117035402B (en) | Drug risk management and control method and system | |
| CN117976125B (en) | Medical equipment management system and method based on data analysis | |
| CN117133476B (en) | Active monitoring method and system for adverse drug reaction | |
| CN110974215B (en) | Early warning system and method based on wireless electrocardiogram monitoring sensor group | |
| CN114334153A (en) | System, method, device and medium for detecting health condition | |
| Alias et al. | Internet of Things Based Heart Failure Monitoring System using Radio Frequency Identification |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |